Pyrimethamine: Difference between revisions
From IDWiki
(Created page with "* Major side effect is bone marrow suppression, so need to monitor CBC") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
* Antimicrobial that inhibits the reduction of dihydrofolic to tetrahydrofolic acid |
|||
⚫ | |||
* Indications include [[Is treatment for::toxoplasmosis]] and [[Is treatment for::malaria]] |
|||
⚫ | |||
** [[Adverse drug reaction::Pancytopenia]], which is reversible with leucovorin |
|||
** [[Adverse drug reaction::GI intolerance]] |
|||
** Other: [[Adverse drug reaction::rash]], [[Adverse drug reaction::hepatitis]], [[Adverse drug reaction::headache]], [[Adverse drug reaction::dizziness]], [[Adverse drug reaction::insomnia]] |
|||
* Monitoring |
|||
** CBC q2d initially, then decreasing frequency |
|||
[[Category:Antibiotics]] |
Latest revision as of 19:10, 20 August 2020
- Antimicrobial that inhibits the reduction of dihydrofolic to tetrahydrofolic acid
- Indications include toxoplasmosis and malaria
- Major adverse effects is bone marrow suppression, so need to monitor CBC
- Pancytopenia, which is reversible with leucovorin
- GI intolerance
- Other: rash, hepatitis, headache, dizziness, insomnia
- Monitoring
- CBC q2d initially, then decreasing frequency